Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART44 versus ART 50 digestive tolerability study in knee osteoarthritis
2009-009990-84Phase 3Active
- Sponsor
- Negma Group
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing ART44 with ART 50 (2 arms). Primary endpoint: Primary digestive tolerability endpoint. Started Aug 2009; status: active.
02
Drugs
ART-44tramadol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-009990-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009990-84.